Nabila Jabrane-Ferrat, Ph.D.

University of California, San Francisco
email:

Grants

Cell-Based Immunotherapy for Breast Cancer 2000 (Cycle VI)
New Investigator 6KB-0116 $120,811


Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers
  Periodical: Molecular and Cellular Biology
  Author(s): Jabrane-Ferrat N, Nekrep N, Tosi G, Esserman LJ, Peterlin BM
  Yr: 2002 Vol: 22 Nbr: 15 Pgs: 5616-25
  Associated Grant: Cell-Based Immunotherapy for Breast Cancer